[go: up one dir, main page]

NO974260L - Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår - Google Patents

Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår

Info

Publication number
NO974260L
NO974260L NO974260A NO974260A NO974260L NO 974260 L NO974260 L NO 974260L NO 974260 A NO974260 A NO 974260A NO 974260 A NO974260 A NO 974260A NO 974260 L NO974260 L NO 974260L
Authority
NO
Norway
Prior art keywords
newly defined
treating wounds
enzyme mixtures
mixtures
obtaining cells
Prior art date
Application number
NO974260A
Other languages
English (en)
Other versions
NO974260D0 (no
Inventor
Claus Otto Markert
Hans Thom
Juergen Weymann
Wolfgang Zahn
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19532906A external-priority patent/DE19532906A1/de
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO974260D0 publication Critical patent/NO974260D0/no
Publication of NO974260L publication Critical patent/NO974260L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Anvendelsen av definert sammensatte blandinger av rensede enzymer fra Clostridium histolyticum til reproduserbar, standardisert utvinning av celler eller vevsfragmenter fra humane eller dyriske vev, samt disse enzymene og deres blandinger, beskrives. Dessuten beskrives den direkte eller indirekte medisinske anvendelse av disse enzymene, for seg eller som bestanddel av blandinger, f eks. ved sårbehandling.
NO974260A 1995-03-16 1997-09-15 Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår NO974260L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19509584 1995-03-16
DE19532906A DE19532906A1 (de) 1995-03-16 1995-09-07 Neue, definierte Enzymmischungen zur Zellgewinnung und für die Wundbehandlung
PCT/EP1996/001044 WO1996028543A1 (de) 1995-03-16 1996-03-12 Neue, definierte enzymmischungen zur zellgewinnung und für die wundbehandlung

Publications (2)

Publication Number Publication Date
NO974260D0 NO974260D0 (no) 1997-09-15
NO974260L true NO974260L (no) 1997-11-14

Family

ID=26013440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974260A NO974260L (no) 1995-03-16 1997-09-15 Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår

Country Status (13)

Country Link
US (1) US6146626A (no)
EP (1) EP0815211A1 (no)
JP (1) JPH11501517A (no)
AU (1) AU702514B2 (no)
BR (1) BR9607143A (no)
CA (1) CA2213723A1 (no)
CZ (1) CZ280397A3 (no)
EA (1) EA000583B1 (no)
HU (1) HUP9901188A2 (no)
IL (1) IL117479A (no)
NO (1) NO974260L (no)
PL (1) PL322271A1 (no)
WO (1) WO1996028543A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718897A (en) * 1995-06-07 1998-02-17 Trustees Of Tufts College Enhancing keratinocyte migration and proliferation
US5830741A (en) * 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US7364565B2 (en) 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
JP4138651B2 (ja) * 2001-07-27 2008-08-27 ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティ アンド アグリカルチュラル アンド メカニカル カレッジ にきび治療または防止のためのボツリヌス毒素
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
MX2012006661A (es) 2009-12-08 2012-11-12 Healthpoint Ltd Composiciones enzimaticas de desbridamiento de heridas con actividad enzimatica mejorada.
BR112014017229B1 (pt) 2012-01-12 2022-05-17 Auxilium International Holdings, Inc Ácido nucleico recombinante, cassette de expressão, vetor, célula hospedeira recombinante, método de produção da colagenase i ou ii, colagenase i ou ii, composição farmacêutica, e método de produção de um produto de droga
JP7558654B2 (ja) 2017-03-01 2024-10-01 エンド ベンチャーズ アンリミテッド カンパニー セルライトを評価及び処置するための装置及び方法
BR112019020394A2 (pt) 2017-03-28 2020-04-22 Endo Ventures Ltd método melhorado de produção de colagenase
CN109694845A (zh) * 2018-12-25 2019-04-30 中国医学科学院北京协和医院 用于分离单细胞的试剂盒及其应用
WO2023228873A1 (ja) * 2022-05-24 2023-11-30 国立研究開発法人国立成育医療研究センター 肝細胞の製造方法、肝細胞の接着性改善剤、および肝細胞

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0673456B2 (ja) * 1986-04-26 1994-09-21 三共株式会社 ヒト・膵臓エラスタ−ゼ▲ｉ▼
US5162205A (en) * 1986-04-26 1992-11-10 Sankyo Company, Limited Human pancreatic elastase I
CA2138948A1 (en) * 1992-06-22 1994-01-06 Hun-Chi Lin Molecular cloning of the genes responsible for collagenase production from clostridium histolyticum
WO1996000283A1 (en) * 1994-06-24 1996-01-04 Boehringer Mannheim Corporation A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum

Also Published As

Publication number Publication date
EA000583B1 (ru) 1999-12-29
CA2213723A1 (en) 1996-09-19
BR9607143A (pt) 1997-11-25
NO974260D0 (no) 1997-09-15
CZ280397A3 (cs) 1998-04-15
PL322271A1 (en) 1998-01-19
IL117479A (en) 1999-12-22
AU5106696A (en) 1996-10-02
US6146626A (en) 2000-11-14
JPH11501517A (ja) 1999-02-09
EP0815211A1 (de) 1998-01-07
MX9706725A (es) 1997-11-29
WO1996028543A1 (de) 1996-09-19
EA199700241A1 (ru) 1998-02-26
HUP9901188A2 (hu) 1999-08-30
IL117479A0 (en) 1996-07-23
AU702514B2 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
NO974260L (no) Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår
ES8505405A1 (es) Un procedimiento para producir un activador de plasminogeno purificado.
DE69525151D1 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
NO944997L (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
AU8476698A (en) Human mesenchymal stem cells from peripheral blood
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
MXPA02007137A (es) Fuente de tejido hepatico.
DE69839815D1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
DE69430315D1 (de) Methoden zur (ex vivo) therapie mittels peptid - bestueckten antigen - praesentierenden zellen zur aktivierung von ctl
DE69738925D1 (de) Verwendung von dna-sequenzenfür männliche sterilität in transgenen pflanzen
DE69029257D1 (de) Anordnung zur bestrahlung von laserstrahlen
DE60139077D1 (de) System zur endotrachealen/ösophagischen stimulation vor und während eines medizinischen verfahrens
DE69327544D1 (de) Mischungen zum schutz und regenierung von geweben
ID30237A (id) KOMBINASI PENGHAMBAT-PENGHAMBAT FBPase DAN PEMEKA-PEMEKA INSULIN UNTUK PENGOBATAN DIABETES
AU7437494A (en) A novel physiologically active substance
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
ATE97316T1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
PT888271E (pt) Derivados de benzamidina substituidos com derivados de aminoacidos e hidroxiacidos e sua utilizacao como anticoagulantes
WO2000028020A3 (en) Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
HU9300397D0 (en) Method for modifying tropism of micor-organisms to cells, tissues and host organisms recombinant micro-organisms obtained by this way and their application in human and veterinary medicine
NO850391L (no) Preparater for kosmetisk, helse- og kroppskonserverende bruk
AU8219801A (en) A method for treating proteinaceous fibres
FI913266A0 (fi) Foerfarande foer infoerande av exogen dna i djurets somatiska och groddceller.
NO933742L (no) Humant, benavledet, insulinlignende vekstfaktorbindingsprotein
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application